Pil Ho KIM

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
CHEIL INDUSTRIES INC.
1
2013
LOTTE ADVANCED MATERIALS CO., LTD.
4
2
3
4
4
6
2009
2010
2011
2012
2013
2014
KATHOLIEKE UNIVERSITEIT LEUVEN
4
2
2012
2016
KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.
1
2012
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
4
2
2012
2016

Inventor Addresses

AddressDuration
Daejeon, KRApr 24, 14 - Mar 13, 25
Daejeongwangyeok-si, KRSep 24, 09 - Dec 14, 10
Gunpo-si, KRDec 27, 12 - Oct 06, 15
Seoul, KRAug 04, 16 - Aug 04, 16
Uiwang-si, KRJun 24, 10 - Jun 07, 22
Yongin-si, KRJan 12, 23 - Jul 04, 23

Technology Profile

Technology Matters
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 4
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2
B32B: LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM 1

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2025/0082,7622025NOVEL BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF0
2025/0073,3412025BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF0
121617222024Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereof0
2024/0285,7782024NOVEL BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF0
2024/0270,6982024NOVEL PYRIMIDINE DERIVATIVE AND USE THEREOF0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.